Genetic Technologies has collaborated with Stayhealthy to promote the use of the Multi-Risk Test on a wider scale across North America's online pharmacy channel.

The collaboration will allow Genetic Technologies to distribute its Multi-Risk Test through Stayhealthy's online platform, StayHealthyRx, expanding the accessibility of personalized health risk assessments. This partnership is expected to give users extensive insights into health risks and advise on practical actions to alleviate them.

Genetic Technologies is a molecular diagnostics company based in Australia, specializing in predictive genetic testing and risk assessment tools. The company operates in the market through its brands AffinityDNA, EasyDNA, and GeneType. Its key product is the GeneType Multi Test, a combination of geneType tests for breast, colorectal, ovarian, and prostate cancer, as well as coronary artery disease and type 2 diabetes.